Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole vs Clomiphene for Ovulation Induction in PCOS
NCT05075863Completed
- Sponsor
- Nishtar Medical University
- Start
- Jan 2021
- Primary completion
- Jun 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of letrozole in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Nishtar Medical University. Primary endpoint: Induction of ovulation assessed by Transvaginal scan (TVS). Started Jan 2021; status: completed.
02
Drugs
letrozole
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT05075863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05075863.